NCT01835314No Longer Available不适用
Compassionate Use of Stiripentol in Dravet Syndrome
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- No Longer Available
- 试验地点
- 1
研究概览
简要总结
Compassionate use of Stiripentol in Dravet Syndrome. This is a treatment protocol, not a research study, therefore children will only be monitored on a clinical basis for seizure improvement predominantly by parent and caregiver report.
详细描述
This is a treatment protocol for compassionate use, not a research study, therefore children will only be monitored on a clinical basis for seizure improvement predominantly by parent and caregiver report.
研究设计
- 研究类型
- Expanded Access
入排标准
- 年龄范围
- 1 Year 至 21 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (1)
Loading locations...
相似试验
撤回
3 期
Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Dravet SyndromeDravet SyndromeNCT02318563INSYS Therapeutics Inc
招募中
3 期
DupuytrEn Treatment EffeCtiveness Trial (DETECT)2024-515110-40-00Pirkanmaan hyvinvointialue, Pirkanmaan hyvinvointialue50
尚未招募
1 期
Turmeric (Daruhaldi) Oil application on Fresh WoundsCTRI/2019/01/017086PDEAs College of Ayurveda and Research Centre
终止
3 期
A Study Evaluating Soticlestat in Participants With Dravet Syndrome or Lennox-Gastaut Syndrome Who Have Been Exposed to FenfluramineDravet Syndrome (DS)Lennox-Gastaut Syndrome (LGS)NCT06422377Takeda1
已完成
3 期
Study of the Safety and Efficacy of Desvenlafaxine Succinate for Vasomotor Symptoms in Postmenopausal WomenVasomotor SystemMenopauseNCT00369434Wyeth is now a wholly owned subsidiary of Pfizer450